Skip to main content
Top
Published in: Respiratory Research 1/2011

Open Access 01-12-2011 | Letter to the Editor

High resolution CT and histological findings in idiopathic pleuroparenchymal fibroelastosis: Features and differential diagnosis

Authors: Sara Piciucchi, Sara Tomassetti, Gianluca Casoni, Nicola Sverzellati, Angelo Carloni, Alessandra Dubini, Giampaolo Gavelli, Alberto Cavazza, Marco Chilosi, Venerino Poletti

Published in: Respiratory Research | Issue 1/2011

Login to get access

Abstract

Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a recently described clinical-pathologic entity characterized by pleural and subpleural parenchymal fibrosis, mainly in the upper lobes. As this disease is extremely rare (only 7 cases have been described in the literature to date) poorly defined cases of IPPFE can go unrecognized.
The clinical course of disease is progressive and prognosis is poor, with no therapeutic options other than lung transplantation currently available, yet. The aim of this report is to describe two further cases of this rare disease, reviewing CT, clinical and histological features.
Appendix
Available only for authorised users
Literature
1.
go back to reference Frankel SK, Cool CD, Lynch DA, Brown K: Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity. Chest. 2004, 126: 2007-2013. 10.1378/chest.126.6.2007.CrossRefPubMed Frankel SK, Cool CD, Lynch DA, Brown K: Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity. Chest. 2004, 126: 2007-2013. 10.1378/chest.126.6.2007.CrossRefPubMed
2.
go back to reference Becker CD, Gil J, Padilla M: Idiopathic pleuroparenchymal fibroelastosis: an unrecognized or misdiagnosed entity?. Mod Pathol. 2008, 21: 784-787. 10.1038/modpathol.2008.56.CrossRefPubMed Becker CD, Gil J, Padilla M: Idiopathic pleuroparenchymal fibroelastosis: an unrecognized or misdiagnosed entity?. Mod Pathol. 2008, 21: 784-787. 10.1038/modpathol.2008.56.CrossRefPubMed
3.
go back to reference Rozin GF, Gomes MM, Parra ER, Kairalla RA, de Carvalho CR, Capelozzi VL: Collagen and elastic system in the remodelling process of major types of idiopathic interstitial pneumonias (IIP). Histopathology. 2005, 46: 413-421. 10.1111/j.1365-2559.2005.02103.x.CrossRefPubMed Rozin GF, Gomes MM, Parra ER, Kairalla RA, de Carvalho CR, Capelozzi VL: Collagen and elastic system in the remodelling process of major types of idiopathic interstitial pneumonias (IIP). Histopathology. 2005, 46: 413-421. 10.1111/j.1365-2559.2005.02103.x.CrossRefPubMed
4.
go back to reference Azoulay E, Paugam B, Heymann MF, et al: Familial extensive idiopathic bilateral pleural fibrosis. Eur Respir J. 1999, 14: 971-973. 10.1034/j.1399-3003.1999.14d41.x.CrossRefPubMed Azoulay E, Paugam B, Heymann MF, et al: Familial extensive idiopathic bilateral pleural fibrosis. Eur Respir J. 1999, 14: 971-973. 10.1034/j.1399-3003.1999.14d41.x.CrossRefPubMed
Metadata
Title
High resolution CT and histological findings in idiopathic pleuroparenchymal fibroelastosis: Features and differential diagnosis
Authors
Sara Piciucchi
Sara Tomassetti
Gianluca Casoni
Nicola Sverzellati
Angelo Carloni
Alessandra Dubini
Giampaolo Gavelli
Alberto Cavazza
Marco Chilosi
Venerino Poletti
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2011
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-12-111

Other articles of this Issue 1/2011

Respiratory Research 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.